Initiative 18|11 explores prescription drug rebates and their impact on consumer pharmacy spend
Actuaries should account for the impact of coupons and PAPs on the health care system
Actuaries should consider DTCPA impact when developing cost projections and setting premium rates
Measuring and understanding cost trends will help address increasing pharmaceutical costs
By understanding the drug pricing process, actuaries can help develop new payment methods
How much money is spent on prescription drugs in the United States
How the process of drug development works and impacts overall health care benefit cost projections
A look at enterprise and financial risk strategy development and support
Actuaries can help refine value-based care objectives and obligations